Nebula Research & Development’s Ocular Therapeutix OCUL Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21,777	Closed	-$112K	–	617
2023 Q2	$112K	Sell	21,777 -697	-3%	-$3.6K	0.09%	295
2023 Q1	$118K	Buy	+22,474	New	+$118K	0.21%	195